ArticlePharmaceutics2022

LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy.

Dmitry Stakheev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.